Neuroprotective NMDA Antagonists: the Controversy over Their Potential for Adverse Effects on Cortical Neuronal Morphology
- 1 January 1994
- book chapter
- Published by Springer Nature
- Vol. 60, 15-19
- https://doi.org/10.1007/978-3-7091-9334-1_4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Lack of effect of L‐687,414 ((+)‐cis‐4‐methyl‐HA‐966)5 an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphologyBritish Journal of Pharmacology, 1993
- SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat cortical neuronsNeuroscience Letters, 1992
- In Vivo Distribution of CGS-19755 Within Brain in a Model of Focal Cerebral IschemiaJournal of Neurochemistry, 1992
- NMDA Antagonist Neurotoxicity: Mechanism and PreventionScience, 1991
- MK‐801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortexAnnals of Neurology, 1991
- Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complexBrain Research, 1991
- Evaluation of a competitive NMDA antagonist (D‐CPPene) in feline focal cerebral ischemiaAnnals of Neurology, 1991
- The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilisationBrain Research, 1990
- Phencyclidine, Dizocilpine, and Cerebrocortical NeuronsScience, 1990
- Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related DrugsScience, 1989